Alejandro M. S. Mayer
About
Alejandro M. S. Mayer is a scholar working on Biotechnology, Pharmacology and Immunology.
According to data from OpenAlex, Alejandro M. S. Mayer has authored 100 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Biotechnology, 26 papers in Pharmacology and 22 papers in Immunology. Recurrent topics in Alejandro M. S. Mayer's work include Marine Sponges and Natural Products (39 papers), Microbial Natural Products and Biosynthesis (19 papers) and Seaweed-derived Bioactive Compounds (18 papers). Alejandro M. S. Mayer is often cited by papers focused on Marine Sponges and Natural Products (39 papers), Microbial Natural Products and Biosynthesis (19 papers) and Seaweed-derived Bioactive Compounds (18 papers). Alejandro M. S. Mayer collaborates with scholars based in United States, Puerto Rico and Argentina. Alejandro M. S. Mayer's co-authors include Mark T. Hamann, Abimael D. Rodrı́guez, Kirk R. Gustafson, Roberto G. S. Berlinck, Nobuhiro Fusetani, Keith B. Glaser, Orazio Taglialatela‐Scafati, Robert S. Jacobs, David Newman and J. A. Spitzer and has published in prestigious journals such as The Journal of Immunology, The FASEB Journal and Journal of Medicinal Chemistry.
In The Last Decade
Alejandro M. S. Mayer
96 papers receiving 3.8k citations
Hit Papers
Peers
Alejandro M. S. Mayer
Pavel S. Dmitrenok Russia
Dale G. Nagle United States
Anake Kijjoa Portugal
Jee H. Jung South Korea
Jongheon Shin South Korea
Ching‐Feng Weng Taiwan
Bin Yang China
Peter Proksch Germany
Xuefeng Zhou China
Hyukjae Choi South Korea
Citations per year, relative to Alejandro M. S. Mayer Alejandro M. S. Mayer (= 1×)
peers
Pavel S. Dmitrenok
Countries citing papers authored by Alejandro M. S. Mayer
Since
Specialization
Citations
This map shows the geographic impact of Alejandro M. S. Mayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro M. S. Mayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro M. S. Mayer more than expected).
Fields of papers citing papers by Alejandro M. S. Mayer
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Alejandro M. S. Mayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro M. S. Mayer. The network helps show where Alejandro M. S. Mayer may publish in the future.
Co-authorship network of co-authors of Alejandro M. S. Mayer
This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro M. S. Mayer. A scholar is included among the top collaborators of Alejandro M. S. Mayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro M. S. Mayer. Alejandro M. S. Mayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Mayer, Alejandro M. S., et al.. (2023). Marine-Derived Pharmaceuticals in Clinical Trials in 2022. Journal of Pharmacology and Experimental Therapeutics. 385. 299–299.
2.
Swanson‐Mungerson, Michelle, et al.. (2023). Impact of the LPS from Cyanobacteria Brasilonema sp. on Lung Inflammation and Glucocorticoid Expression. The Journal of Immunology. 210(Supplement_1). 67.27–67.27.
3.
Mayer, Alejandro M. S., Marsha L. Pierce, Abimael D. Rodrı́guez, et al.. (2022). Marine pharmacology in 2018: Marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action. Pharmacological Research. 183. 106391–106391.
4.
Mayer, Alejandro M. S., et al.. (2015). Classical and Alternative Activation of CyanobacteriumOscillatoriasp. Lipopolysaccharide-Treated Rat Microgliain vitro. Toxicological Sciences. 149(2). 484–495.
5.
Jiménez‐Romero, Carlos, Alejandro M. S. Mayer, & Abimael D. Rodrı́guez. (2013). Dactyloditerpenol acetate, a new prenylbisabolane-type diterpene from Aplysia dactylomela with significant in vitro anti-neuroinflammatory activity. Bioorganic & Medicinal Chemistry Letters. 24(1). 344–348.
6.
Mayer, Alejandro M. S., et al.. (2011). Cyanobacterial Microcystis aeruginosa Lipopolysaccharide Elicits Release of Superoxide Anion, Thromboxane B2, Cytokines, Chemokines, and Matrix Metalloproteinase-9 by Rat Microglia. Toxicological Sciences. 121(1). 63–72.
7.
Mayer, Alejandro M. S., et al.. (2011). Marine sponge Hymeniacidon sp. amphilectane metabolites potently inhibit rat brain microglia thromboxane B2 generation. Bioorganic & Medicinal Chemistry. 20(1). 279–282.
8.
Mayer, Alejandro M. S., Abimael D. Rodrı́guez, Roberto G. S. Berlinck, & Nobuhiro Fusetani. (2010). Marine pharmacology in 2007–8: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous system, and other miscellaneous mechanisms of action. Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology. 153(2). 191–222.
9.
Mayer, Alejandro M. S., Keith B. Glaser, Carmen Cuevas, et al.. (2010). The odyssey of marine pharmaceuticals: a current pipeline perspective. Trends in Pharmacological Sciences. 31(6). 255–265.
10.
Mayer, Alejandro M. S., Abimael D. Rodrı́guez, Roberto G. S. Berlinck, & Mark T. Hamann. (2009). Marine pharmacology in 2005–6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action. Biochimica et Biophysica Acta (BBA) - General Subjects. 1790(5). 283–308.
11.
Mayer, Alejandro M. S., Abimael D. Rodrı́guez, Roberto G. S. Berlinck, & Mark T. Hamann. (2007). Marine pharmacology in 2003–4: Marine compounds with anthelmintic antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action. Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology. 145(4). 553–581.
12.
Mayer, Alejandro M. S., Mary L. Hall, Michael J. Fay, et al.. (2007). Differential Effects of Domoic Acid and E. coli Lipopolysaccharide on Tumor Necrosis Factor-α, Transforming Growth Factor-β1 and Matrix Metalloproteinase-9 Release by Rat Neonatal Microglia: Evaluation of the Direct Activation Hypothesis. Marine Drugs. 5(3). 113–135.
13.
Mayer, Alejandro M. S. & Mark T. Hamann. (2004). Marine Pharmacology in 2000: Marine Compounds with Antibacterial, Anticoagulant, Antifungal, Anti-inflammatory, Antimalarial, Antiplatelet, Antituberculosis, and Antiviral Activities; Affecting the Cardiovascular, Immune, and Nervous Systems and Other Miscellaneous Mechanisms of Action. Marine Biotechnology. 6(1). 37–52.
14.
Mayer, Alejandro M. S. & Mark T. Hamann. (2002). Marine pharmacology in 1999: compounds with antibacterial, anticoagulant, antifungal, anthelmintic, anti-inflammatory, antiplatelet, antiprotozoal and antiviral activities affecting the cardiovascular, endocrine, immune and nervous systems, and other miscellaneous mechanisms of action. Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology. 132(3). 315–339.
15.
Mayer, Alejandro M. S.. (2002). Marine pharmacology in 1999 : compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, anthelmintic, anti-inflammatory, antiplatelet, antiprotozoal and antiviral activities ; affecting the cardiovascular, endocrine, immune, and nervous systems ; and other miscellaneous mechanisms of action. Comparative Biochemistry and Physiology Part C Pharmacology Toxicology and Endocrinology. 132. 315–339.
16.
Mayer, Alejandro M. S., Mary L. Hall, Michael J. Fay, et al.. (2001). Effect of a short-term in vitro exposure to the marine toxin domoic acid on viability, tumor necrosis factor-alpha, matrix metalloproteinase-9 and superoxide anion release by rat neonatal microglia. BMC Pharmacology. 1(1). 7–7.
17.
Mayer, Alejandro M. S., et al.. (2000). Marine pharmacology in 1998: Marine compounds with antibacterial, anticoagulant, antifungal, antiinflammatory, anthelmintic, antiplatelet, antiprotozoal, and antiviral activities; with actions on the cardiovascular, endocrine, immune, and nervous systems; and other miscellaneous mechanisms of action.
18.
Mayer, Alejandro M. S. & J. A. Spitzer. (1994). Modulation of superoxide generation in in vivo lipopolysaccharide-primed Kupffer cells by staurosporine, okadaic acid, manoalide, arachidonic acid, genistein and sodium orthovanadate.. Journal of Pharmacology and Experimental Therapeutics. 268(1). 238–247.
19.
Pomilio, Alicia B., et al.. (1994). Antitumor and cytotoxic screen of 5,6,7-trisubstituted flavones from Gomphrena martiana. Journal of Ethnopharmacology. 44(1). 25–33.
20.
Spitzer, Judy A. & Alejandro M. S. Mayer. (1993). Hepatic Neutrophil Influx: Eicosanoid and Superoxide Formation in Endotoxemia. Journal of Surgical Research. 55(1). 60–67.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Pavel S. Dmitrenok Breakdown of academic impact, for papers by Dale G. Nagle Breakdown of academic impact, for papers by Anake Kijjoa Breakdown of academic impact, for papers by Jee H. Jung Breakdown of academic impact, for papers by Jongheon Shin Breakdown of academic impact, for papers by Ching‐Feng Weng Breakdown of academic impact, for papers by Bin Yang Breakdown of academic impact, for papers by Peter Proksch Breakdown of academic impact, for papers by Xuefeng Zhou Breakdown of academic impact, for papers by Hyukjae Choi